Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY3857210 for Diabetic Peripheral Neuropathic Pain
NCT05620576Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of RQ-00466479 in diabetic polyneuropathy (DPN), sponsored by Eli Lilly and Company. Started Nov 2022; status: completed.
02
Drugs
RQ-00466479
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT05620576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05620576.